Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer

R. F. H. Walter, P. Rozynek*, S. Casjens, R. Werner, F. D. Mairinger, E. J. M. Speel, A. Zur Hausen, S. Meier, J. Wohlschlaeger, D. Theegarten, T. Behrens, K. W. Schmid, T. Bruning, G. Johnen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Web of Science)
Original languageEnglish
Article numbere0195716
Pages (from-to)1
Number of pages17
JournalPLOS ONE
Volume13
Issue number5
DOIs
Publication statusPublished - 31 May 2018

Keywords

  • PROMOTER METHYLATION
  • NEUROENDOCRINE TUMORS
  • METAANALYSIS
  • SUPPRESSOR
  • CDKN2A
  • LINE1
  • DNA
  • TUMOR-SUPPRESSOR

Cite this